Average Co-Inventor Count = 2.12
ph-index = 9
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Acceleron Pharma Inc. (10 from 167 patents)
2. Other (1 from 832,880 patents)
3. Wyeth (1 from 1,309 patents)
4. Genetics Institute, Inc. (1 from 389 patents)
13 patents:
1. 11524990 - Methods for treating vascular eye disorders with ActRII antagonists
2. 10550170 - Methods for treating vascular eye disorders with actrii antagonists
3. 10093707 - Antagonists of activin-ActRIIa and uses for increasing red blood cell levels
4. 9919030 - Follistatin fusion proteins and uses thereof
5. 9353356 - Activin-actriia antagonists for treating a follicle-stimulating horomone-secreting pituitary tumor
6. 8895016 - Antagonists of activin-actriia and uses for increasing red blood cell levels
7. 8367611 - Activin-actriia antagonists for inhibiting germ cell maturation
8. 8007809 - Activin-actrii antagonists and uses for increasing red blood cell levels
9. 7988973 - Activin-ActRII antagonists and uses for increasing red blood cell levels
10. 7960343 - Activin-ActRIIa antagonists and uses for decreasing or inhibiting FSH secretion
11. 7727968 - Combination therapy for the treatment of acute leukemia and myelodysplastic syndrome
12. 6509321 - Treatment of Kaposi's sarcoma with IL-12
13. 6423308 - Treatment of Kaposi's sarcoma with IL-12